We understand the frustration of shedding pounds only to see them creep back on
Clinicians can adjust dose or timing, evaluate underlying causes (hormones, medication interactions, psychological factors), or combine with other therapies
TRIUMPH-4 (retatrutide, 68 weeks): Discontinuation due to AEs: 12.2% (9 mg), 18.2% (12 mg) vs 4.0% placebo Key characteristics: Highest GI adverse event rates among the drugs compared here Dysesthesia is a novel safety signal -- abnormal touch sensations affecting up to 21% at the 12 mg dose, not seen in Phase 2
8 The most reliable approach is to start small and link the habit to something you already do, like a 10-minute walk after dinner
This includes selecting and preparing an appropriate dose with an experienced doctor, properly rotating injection sites on the upper arm, leg, or abdomen according to each patients particular needs, and being aware of possible side effects like dizziness and nausea